You are here: Home :: Keyword index :: com bis DIC :: decay resistance - definitions deep vein thrombosis

Items for "deep vein thrombosis"

Idiopathic venous thrombosis. Long-term anticoagulation therapy? Yes

Idiopathic venous thromboembolism has been shown to be associated with a high frequency of recurrence...

Keywords: venöse Thromboembolie, Langzeitantikoagulation, sekundäre Prävention, tiefe Venenthrombose, L

01/2006 | Hämostaseologie, Schattauer

Neutrophils modulate post-thrombotic vein wall remodeling but not thrombus neovascularization

Early deep venous thrombosis (DVT) resolution is associated with neutrophil (PMN) influx. This study examined the role of PMNs in thrombus neovascularization and vein wall injury after DVT...

Keywords: Animal models, tissue remodelling, leukocyte function / activation, deep vein thrombosis

00/0000 | Thrombosis and Haemostasis, Schattauer

The magnitude of an iatrogenic disorder: A systematic review of the incidence of venous thromboembolism for general medical inpatients

Venous thromboembolism (VTE) is recognized as a potential serious complication of hospitalization, and anticoagulant prophylaxis is widely recommended for medical inpatients...

Keywords: Venous thromboembolism, anticoagulation, prophylaxis, deep vein thrombosis, pulmonary embolism

05/2006 | Thrombosis and Haemostasis, Schattauer

Antiphospholipid antibodies and hyperhomocysteinaemia in patients with vascular occlusive disease

Hyperhomocysteinemia (HHcy), lupus anticoagulant (LA) and anticardiolipin antibodies (ACA) are independent risk factors for thrombosis...

Keywords: clinical / epidemiological studies, homocysteine, antiphospholipid antibodies, deep vein thrombosis, Cerebrovascular disease

07/2006 | Thrombosis and Haemostasis, Schattauer

Interleukin-10 promoter polymorphism and venous thrombosis: A case-control study

The human interleukin-10 promoter gene is highly polymorphic. IL-10 polymorphisms have been associated with various autoimmune and lymphoproliferative disorders...

Keywords: deep vein thrombosis, interleukin-10, factor V Leiden, hereditary thrombosis risk factor

07/2006 | Thrombosis and Haemostasis, Schattauer

Sensitivity and specificity of a quantitative point of care D-dimer assay using heparinized whole blood, in patients with clinically suspected deep vein thrombosis

D-dimer assays are efficient in the exclusion diagnostics of deep vein thrombosis (DVT) in patients without severe concomitant diseases...

Keywords: deep vein thrombosis, D-dimer, point-of-care assay

07/2006 | Thrombosis and Haemostasis, Schattauer

Initial treatment of venous thromboembolism

Immediate anticoagulant treatment is essential to reduce morbidity and mortality in patients with acute venous thromboembolism (VTE)...

Keywords: Venous thromboembolism, deep vein thrombosis, pulmonary embolism, heparin, Low-molecular-weight heparin, anticoagulants

09/2006 | Thrombosis and Haemostasis, Schattauer

Role of fibrinolysis and interventional therapy for acute venous thromboembolism

The initial goals of treatment for venous thromboembolism (VTE) are usually achieved with anticoagulation...

Keywords: deep vein thrombosis, pulmonary embolism, fibrinolysis, thrombolysis, inferior vena cava filter

09/2006 | Thrombosis and Haemostasis, Schattauer

Emerging anticoagulants for the treatment of venous thromboembolism

Anticoagulant therapy is the cornerstone of treatment of venous thromboembolism (VTE). Such treatment is divided into two stages...

Keywords: Coagulation inhibitors, heparins / glycosaminoglycans, pulmonary embolism, deep vein thrombosis

09/2006 | Thrombosis and Haemostasis, Schattauer

Prevention effect of orally active heparin derivative on deep vein thrombosis

The use of heparin as the most potent anticoagulant for the prevention of deep vein thrombosis and pulmonary embolism is nevertheless limited, because it is available to patients only by parenteral administration...

Keywords: Low-molecular-weight heparin, deoxycholic acid, chemical conjugate, oral delivery, deep vein thrombosis

08/2006 | Thrombosis and Haemostasis, Schattauer

Relationship between methionine synthase, methionine synthase reductase genetic polymorphisms and deep vein thrombosis among South Indians

Background: The rationale behind this study was to examine the relationship between polymorphisms in genes that regulate remethylation of homocysteine to methionine, i.e., methionine synthase (MTR A2756G) and methionine synthase reductase (MTRR A66G), and risk of deep vein thrombosis (DVT) in a South Indian cohort (163 DVT cases and 163 controls), as elevated homocysteine has been documented as an independent risk factor for DVT in the same cohort.

Methods: Plasma homocysteine analysis was carried out by reverse phase HPLC...

Keywords: deep vein thrombosis, methionine synthase, methionine synthase reductase, single nucleotide polymorphisms

01/2008 | Clinical Chemical Laboratory Medicine, Walter de Gruyter

Publisher and Institutes

You are here: Home :: Keyword index :: com bis DIC :: decay resistance - definitions deep vein thrombosis

Items for "deep vein thrombosis"